Biotech · Private company
Encube Ethicals Pvt. Ltd.
Track this companyFree. Adds Encube Ethicals Pvt. Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- Diclofenac Sodium GelPhase 3 · Actinic KeratosesClinicalTrials.gov · fetched Nov 12, 2026
- Elimite™ Cream (permethrin) 5%Phase 3 · ScabiesClinicalTrials.gov · fetched Nov 12, 2026
- Ketoconazole Cream 2%Phase 3 · Tinea PedisClinicalTrials.gov · fetched Nov 12, 2026
- Ketoconazole Cream 2% (G&W Laboratories Inc.)Phase 3 · Tinea PedisClinicalTrials.gov · fetched Nov 12, 2026
- Permethrin Cream, 5%Phase 3 · ScabiesClinicalTrials.gov · fetched Nov 12, 2026
- Reference Product (B): Fluorouracil 5% Topical Cream of Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.Phase 3 · Actinic KeratosesClinicalTrials.gov · fetched Nov 12, 2026
- Solaraze 3% Topical GelPhase 3 · Actinic KeratosesClinicalTrials.gov · fetched Nov 12, 2026
- Test Product (A): Fluorouracil Cream, 5% topical creamPhase 3 · Actinic KeratosesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic KeratosisPHASE3 · COMPLETED · started Mar 1, 2022ClinicalTrials.gov NCT05078827 · fetched Nov 12, 2026
- Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea PedisPHASE3 · COMPLETED · started Aug 23, 2018ClinicalTrials.gov NCT03824912 · fetched Nov 12, 2026
- Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic KeratosisPHASE3 · COMPLETED · started Jan 12, 2018ClinicalTrials.gov NCT03826550 · fetched Nov 12, 2026
- Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% in the Treatment of ScabiesPHASE3 · COMPLETED · started Jun 1, 2017ClinicalTrials.gov NCT03178942 · fetched Nov 12, 2026